27.93
price down icon6.02%   -1.79
after-market After Hours: 28.14 0.21 +0.75%
loading
Lenz Therapeutics Inc stock is traded at $27.93, with a volume of 1.50M. It is down -6.02% in the last 24 hours and down -42.70% over the past month. LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
See More
Previous Close:
$29.72
Open:
$29.64
24h Volume:
1.50M
Relative Volume:
1.88
Market Cap:
$796.62M
Revenue:
-
Net Income/Loss:
$-69.47M
P/E Ratio:
-4.9899
EPS:
-5.5973
Net Cash Flow:
$-73.92M
1W Performance:
-10.74%
1M Performance:
-42.70%
6M Performance:
-5.39%
1Y Performance:
+0.00%
1-Day Range:
Value
$27.10
$29.64
1-Week Range:
Value
$27.10
$32.00
52-Week Range:
Value
$16.54
$50.40

Lenz Therapeutics Inc Stock (LENZ) Company Profile

Name
Name
Lenz Therapeutics Inc
Name
Phone
858-925-7000
Name
Address
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Name
Employee
42
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
LENZ's Discussions on Twitter

Compare LENZ with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LENZ
Lenz Therapeutics Inc
27.93 899.65M 0 -69.47M -73.92M -5.5973
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-14-25 Resumed Piper Sandler Overweight
Mar-18-25 Initiated TD Cowen Buy
Sep-27-24 Initiated Raymond James Outperform
Aug-12-24 Initiated H.C. Wainwright Buy
Apr-15-24 Initiated Leerink Partners Outperform
Apr-15-24 Initiated William Blair Outperform
Apr-10-24 Initiated Citigroup Buy
Mar-27-24 Initiated Piper Sandler Overweight
Feb-23-23 Downgrade BofA Securities Neutral → Underperform
Feb-23-23 Downgrade Cantor Fitzgerald Overweight → Neutral
Feb-23-23 Downgrade Cowen Outperform → Market Perform
Jan-25-23 Downgrade BTIG Research Buy → Neutral
Jan-18-23 Downgrade BofA Securities Buy → Neutral
Jan-06-23 Downgrade BMO Capital Markets Outperform → Market Perform
Jan-06-23 Downgrade SVB Leerink Outperform → Mkt Perform
Sep-15-22 Initiated Cantor Fitzgerald Overweight
Jun-17-22 Initiated BMO Capital Markets Outperform
Apr-14-22 Initiated BTIG Research Buy
Mar-22-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-18-22 Initiated RBC Capital Mkts Sector Perform
Jul-20-21 Initiated Morgan Stanley Overweight
Jul-20-21 Initiated SVB Leerink Outperform
View All

Lenz Therapeutics Inc Stock (LENZ) Latest News

pulisher
Nov 03, 2025

Analyzing drawdowns of LENZ Therapeutics Inc. with statistical tools2025 Short Interest & Accurate Buy Signal Notifications - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Has LENZ Therapeutics Inc. formed a bullish divergenceJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How LENZ Therapeutics Inc. stock reacts to oil pricesJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why LENZ Therapeutics Inc. stock remains on watchlistsJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Chart overlay techniques for tracking LENZ Therapeutics Inc.Insider Selling & Stock Portfolio Risk Management - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is LENZ Therapeutics Inc. trending in predictive chart modelsJuly 2025 Decliners & Weekly Top Performers Watchlists - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How LENZ Therapeutics Inc. stock reacts to Fed rate cutsMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Combining price and volume data for LENZ Therapeutics Inc.Day Trade & AI Driven Stock Price Forecasts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Ranking LENZ Therapeutics Inc. among high performing stocks via toolsJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time scanner hits for LENZ Therapeutics Inc. explainedJuly 2025 Selloffs & Real-Time Volume Analysis - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 03:22:46 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What does recent volatility data suggest for LENZ Therapeutics Inc.Buy Signal & Community Verified Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What risks investors should watch in LENZ Therapeutics Inc. stockJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Signal strength of LENZ Therapeutics Inc. stock in tech scannersWeekly Stock Analysis & Real-Time Buy Zone Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will LENZ Therapeutics Inc. continue its uptrendJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is LENZ Therapeutics Inc. stock ready for a breakoutJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Analyzing net buyer seller activity in LENZ Therapeutics Inc.2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Why LENZ Therapeutics Inc. stock is trending among retail tradersGlobal Markets & Daily Chart Pattern Signal Reports - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Is LENZ Therapeutics Inc. stock a buy in volatile marketsWeekly Trade Report & Low Risk High Reward Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will LENZ Therapeutics Inc. stock see PE expansionWeekly Profit Summary & Fast Exit and Entry Strategy Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How LENZ Therapeutics Inc. stock trades before earningsPortfolio Gains Report & High Win Rate Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How interest rate cuts could boost LENZ Therapeutics Inc. stockShort Setup & Smart Swing Trading Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Why LENZ Therapeutics Inc. stock remains undervaluedQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

LENZ Therapeutics, Inc. (LENZ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - sharewise.com

Oct 30, 2025

Lenz Therapeutics Inc Stock (LENZ) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Cap:     |  Volume (24h):